STOCK TITAN

[Form 4] Hippo Holdings Inc. Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Richard McCathron, Chief Executive Officer and Director of Hippo Holdings Inc. (HIPO), reported an open-market sale of 10,759 shares of Hippo common stock on 08/15/2025 at a price of $30.91 per share. After the reported disposition, McCathron beneficially owned 475,388 shares, which the filing notes includes 212,464 RSUs. The Form 4 was signed by an attorney-in-fact on 08/18/2025. The filing discloses the transaction and the remaining stake but does not provide context such as whether the sale was pursuant to a pre-arranged trading plan or for personal reasons.

Richard McCathron, amministratore delegato e membro del consiglio di Hippo Holdings Inc. (HIPO), ha comunicato la vendita sul mercato aperto di 10.759 azioni ordinarie di Hippo in data 15/08/2025 al prezzo di $30,91 per azione. Dopo la cessione dichiarata, McCathron deteneva beneficiariamente 475.388 azioni, comprensive di 212.464 RSU come riportato nel deposito. Il Modulo 4 è stato firmato da un procuratore il 18/08/2025. Il documento rende nota la transazione e la partecipazione residua, ma non specifica se la vendita sia avvenuta nell'ambito di un piano di negoziazione predefinito o per motivi personali.

Richard McCathron, director ejecutivo y miembro del consejo de Hippo Holdings Inc. (HIPO), notificó una venta en mercado abierto de 10.759 acciones ordinarias de Hippo el 15/08/2025 a un precio de $30,91 por acción. Tras la disposición informada, McCathron poseía beneficiariamente 475.388 acciones, que el informe indica incluyen 212.464 RSU. El Formulario 4 fue firmado por un apoderado el 18/08/2025. La presentación divulga la transacción y la participación restante, pero no aclara si la venta se realizó bajo un plan de negociación preestablecido o por motivos personales.

리처드 맥캐서런(Richard McCathron) 은 Hippo Holdings Inc. (HIPO) 의 최고경영자 겸 이사로서 2025-08-15에 Hippo 보통주 10,759주를 주당 $30.91에 공개시장 매도했다고 보고했습니다. 보고된 처분 이후 맥캐서런은 475,388주를 실질적으로 보유하고 있으며, 제출서류는 이 중 212,464주가 RSU 포함되어 있다고 적시하고 있습니다. 양식(Form 4)은 2025-08-18에 대리인(변호사대리인)에 의해 서명되었습니다. 제출서류는 거래 내용과 잔여 지분을 공개하고 있으나, 해당 매도가 사전 설정된 거래계획에 따른 것인지 개인적 사유인지 등 배경은 밝히지 않고 있습니다.

Richard McCathron, directeur général et administrateur de Hippo Holdings Inc. (HIPO), a déclaré une vente sur le marché ouvert de 10 759 actions ordinaires Hippo le 15/08/2025 au prix de 30,91 $ par action. Après la cession déclarée, McCathron détenait bénéficiairement 475 388 actions, la déclaration précisant que 212 464 RSU sont incluses. Le formulaire 4 a été signé par un mandataire le 18/08/2025. Le dépôt divulgue la transaction et la participation restante, mais ne précise pas si la vente s'inscrivait dans le cadre d'un plan de négociation préétabli ou résulte de motifs personnels.

Richard McCathron, Chief Executive Officer und Direktor von Hippo Holdings Inc. (HIPO), meldete am 15.08.2025 einen Verkauf von 10.759 Aktien der Hippo-Stammaktien im freien Handel zu einem Preis von $30,91 pro Aktie. Nach der gemeldeten Veräußerung besaß McCathron wirtschaftlich 475.388 Aktien, wobei die Einreichung angibt, dass 212.464 RSUs darin enthalten sind. Das Formular 4 wurde am 18.08.2025 von einem Bevollmächtigten unterzeichnet. Die Meldung offenbart die Transaktion und die verbleibende Beteiligung, nennt aber nicht, ob der Verkauf im Rahmen eines vorab vereinbarten Handelsplans oder aus persönlichen Gründen erfolgte.

Positive
  • Timely disclosure of insider transaction via Form 4, filed and signed by attorney-in-fact
  • Substantial retained stake: reporting person beneficially owns 475,388 shares including 212,464 RSUs
Negative
  • Insider disposition of 10,759 shares on 08/15/2025 at $30.91 per share
  • No stated 10b5-1 plan or rationale is included in the filing, so the reason for the sale is not disclosed

Insights

TL;DR: Insider sale of 10,759 shares is disclosed; remaining stake of 475,388 shares includes substantial RSUs.

The reported sale on 08/15/2025 at $30.91 per share reduces the CEO's direct holdings but leaves a sizeable beneficial position of 475,388 shares including 212,464 RSUs. From a liquidity and signaling perspective, the Form 4 documents transparency around insider activity. The filing does not state a 10b5-1 plan or other pre-arrangement, so readers cannot determine whether the sale was routine diversification or opportunistic. No derivative transactions or additional disposals are reported.

TL;DR: Timely Form 4 filing shows compliance; sale noted but governance implications depend on undisclosed context.

The Form 4 was filed by a single reporting person and signed by an attorney-in-fact, indicating proper procedural handling. The report lists the CEO also as a director and confirms both direct ownership and RSU holdings. Absent disclosure of a trading plan or the proportional size of the sale relative to total holdings, governance interpretation remains neutral: the company complied with Section 16 reporting but did not provide explanatory context in the filing itself.

Richard McCathron, amministratore delegato e membro del consiglio di Hippo Holdings Inc. (HIPO), ha comunicato la vendita sul mercato aperto di 10.759 azioni ordinarie di Hippo in data 15/08/2025 al prezzo di $30,91 per azione. Dopo la cessione dichiarata, McCathron deteneva beneficiariamente 475.388 azioni, comprensive di 212.464 RSU come riportato nel deposito. Il Modulo 4 è stato firmato da un procuratore il 18/08/2025. Il documento rende nota la transazione e la partecipazione residua, ma non specifica se la vendita sia avvenuta nell'ambito di un piano di negoziazione predefinito o per motivi personali.

Richard McCathron, director ejecutivo y miembro del consejo de Hippo Holdings Inc. (HIPO), notificó una venta en mercado abierto de 10.759 acciones ordinarias de Hippo el 15/08/2025 a un precio de $30,91 por acción. Tras la disposición informada, McCathron poseía beneficiariamente 475.388 acciones, que el informe indica incluyen 212.464 RSU. El Formulario 4 fue firmado por un apoderado el 18/08/2025. La presentación divulga la transacción y la participación restante, pero no aclara si la venta se realizó bajo un plan de negociación preestablecido o por motivos personales.

리처드 맥캐서런(Richard McCathron) 은 Hippo Holdings Inc. (HIPO) 의 최고경영자 겸 이사로서 2025-08-15에 Hippo 보통주 10,759주를 주당 $30.91에 공개시장 매도했다고 보고했습니다. 보고된 처분 이후 맥캐서런은 475,388주를 실질적으로 보유하고 있으며, 제출서류는 이 중 212,464주가 RSU 포함되어 있다고 적시하고 있습니다. 양식(Form 4)은 2025-08-18에 대리인(변호사대리인)에 의해 서명되었습니다. 제출서류는 거래 내용과 잔여 지분을 공개하고 있으나, 해당 매도가 사전 설정된 거래계획에 따른 것인지 개인적 사유인지 등 배경은 밝히지 않고 있습니다.

Richard McCathron, directeur général et administrateur de Hippo Holdings Inc. (HIPO), a déclaré une vente sur le marché ouvert de 10 759 actions ordinaires Hippo le 15/08/2025 au prix de 30,91 $ par action. Après la cession déclarée, McCathron détenait bénéficiairement 475 388 actions, la déclaration précisant que 212 464 RSU sont incluses. Le formulaire 4 a été signé par un mandataire le 18/08/2025. Le dépôt divulgue la transaction et la participation restante, mais ne précise pas si la vente s'inscrivait dans le cadre d'un plan de négociation préétabli ou résulte de motifs personnels.

Richard McCathron, Chief Executive Officer und Direktor von Hippo Holdings Inc. (HIPO), meldete am 15.08.2025 einen Verkauf von 10.759 Aktien der Hippo-Stammaktien im freien Handel zu einem Preis von $30,91 pro Aktie. Nach der gemeldeten Veräußerung besaß McCathron wirtschaftlich 475.388 Aktien, wobei die Einreichung angibt, dass 212.464 RSUs darin enthalten sind. Das Formular 4 wurde am 18.08.2025 von einem Bevollmächtigten unterzeichnet. Die Meldung offenbart die Transaktion und die verbleibende Beteiligung, nennt aber nicht, ob der Verkauf im Rahmen eines vorab vereinbarten Handelsplans oder aus persönlichen Gründen erfolgte.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
McCathron Richard

(Last) (First) (Middle)
C/O HIPPO HOLDINGS INC. 1 ALMADEN BLVD
SUITE 400

(Street)
SAN JOSE CA 95113

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Hippo Holdings Inc. [ HIPO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/15/2025 F 10,759 D $30.91 475,388(1) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Includes 212,464 RSUs.
Remarks:
/s /Guy Zeltser, Attorney-in-Fact for Richard McCathron 08/18/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Hippo Holdings CEO Richard McCathron report on Form 4 (HIPO)?

The CEO reported a sale of 10,759 shares on 08/15/2025 at $30.91 per share and now beneficially owns 475,388 shares including 212,464 RSUs.

When was the Form 4 for HIPO filed and who signed it?

The Form 4 indicates the transaction date of 08/15/2025 and the filing was signed by an attorney-in-fact on 08/18/2025.

Does the Form 4 state if the sale was under a 10b5-1 trading plan?

No. The filing does not indicate that the transaction was made pursuant to a 10b5-1 plan or provide a rationale for the sale.

How many RSUs are included in Richard McCathron's beneficial ownership?

The filing explicitly states that the beneficial ownership of 475,388 shares includes 212,464 RSUs.

Was any derivative security reported in this Form 4 for HIPO?

No derivative securities were reported in Table II; only a non-derivative sale of common stock is recorded.
Hippo Hldgs Inc

NYSE:HIPO

HIPO Rankings

HIPO Latest News

HIPO Latest SEC Filings

HIPO Stock Data

782.13M
19.21M
23.24%
47.9%
2.46%
Insurance - Property & Casualty
Fire, Marine & Casualty Insurance
Link
United States
SAN JOSE